Scientists have discovered a new metabolic process in the body that can switch off inflammation. They have discovered that ‘itaconate’ – a molecule derived from glucose – acts as a powerful off-switch for macrophages, which are the cells in the immune system that lie at the heart of many inflammatory diseases including arthritis, inflammatory bowel disease and heart disease.
The scientists, working in the School of Biochemistry and Immunology in the Trinity Biomedical Sciences Institute at Trinity College Dublin, hope their discovery will have relevance for inflammatory and infectious diseases – and that their findings may also help to develop much-needed new drugs to treat people living with these conditions.
Professor of Biochemistry at Trinity, Luke O’Neill, was, along with Dr Mike Murphy of the University of Cambridge, the joint leader of the work just published in leading international journal Nature. The discoveries were made using both human cells and mice as a model organism.
Professor O’Neill said: “My lab has been exploring metabolic changes in macrophages for the past six years and we’ve come across what we think is the most important finding yet.”
“It is well known that macrophages cause inflammation, but we have just found that they can be coaxed to make a biochemical called itaconate. This functions as an important brake, or off-switch, on the macrophage, cooling the heat of inflammation in a process never before described.”
Dr Evanna Mills, who, with Dylan Ryan was joint first author of the work, said: “The macrophage takes the nutrient glucose, whose day job it is to provide energy, and surprisingly turns it into itaconate. This then blocks production of inflammatory factors, and also protects mice from the lethal inflammation that can occur during infection.”
Dylan Ryan added: “We’ve found that itaconate can directly modify a whole host of proteins important for inflammation in a chemical reaction never before described, and that this reaction is important for the anti-inflammatory effects of itaconate.”
The discovery is very much on the frontier of inflammation research and Professor O’Neill and his collaborators are now exploring its relevance to the onset and development of inflammatory and infectious diseases. They are also keen to explore whether the findings can be exploited in the effort to develop new anti-inflammatory medicines.
The work was a collaboration with Harvard Medical School, the University of Cambridge, the University of Oxford, Johns Hopkins University, the University of Dundee, and GlaxoSmithKline, where both Professor O’Neill and Dr Mills spent time on sabbatical.
Professor O’Neill said: “This discovery and the new research pathways it has opened up will keep us busy for some time but we are hopeful that it will one day make a difference to patients with diseases that remain difficult to treat.”
The Latest on: Inflammation
via Google News
The Latest on: Inflammation
- New study explains how inflammation causes gastric cancer on April 17, 2019 at 6:15 am
In 1982, researchers reported a link between chronic gastritis and stomach bacterium Helicobacter pylori, triggering a flurry of research into this newly identified pathogen. These studies made it ... […]
- Can purple corn reduce inflammation, diabetes? on April 17, 2019 at 4:10 am
Eating a healthful diet is a cornerstone of the prevention and management of type 2 diabetes. Fruit, nonstarchy vegetables, whole grains, nuts, seeds, and legumes are all on the list of foods that the ... […]
- This gene could reduce inflammation after stroke on April 17, 2019 at 4:00 am
Researchers have found that a gene could help the brain heal itself after a stroke or any other head-related injuries. The study, published in Cell Reports, suggested that a dose of the TRIM9 gene ... […]
- Effects of rikkunshito on renal fibrosis and inflammation in angiotensin II-infused mice on April 17, 2019 at 2:24 am
The underlying pathogenesis of chronic kidney disease involves an activated renin-angiotensin system and systemic inflammation which ultimately develop renal injury. Rikkunshito (RKT) has been ... […]
- Major vault protein suppresses obesity and atherosclerosis through inhibiting IKK–NF-κB signaling mediated inflammation on April 17, 2019 at 2:22 am
Macrophage-orchestrated, low-grade chronic inflammation plays a pivotal role in obesity and atherogenesis. However, the underlying regulatory mechanisms remain incompletely understood. Here, we ... […]
- Japanese researchers explain how inflammation causes gastric tumors on April 16, 2019 at 2:23 pm
In 1982, researchers reported a link between chronic gastritis and stomach bacterium Helicobacter pylori, triggering a flurry of research into this newly-identified pathogen. These studies made it ... […]
- Exercise Cuts Brain Inflammation in First-Episode Psychosis on April 16, 2019 at 9:24 am
ORLANDO, Florida — Aerobic exercise reduces brain inflammation in patients with first-episode psychosis (FEP), early research suggests. In a study involving 25 outpatients newly diagnosed with ... […]
- How inflammation causes gastric cancer on April 16, 2019 at 6:49 am
Researchers have solved the decades-old mystery of how stomach bacterium Helicobacter pylori causes gastric cancer. Using mouse models and human cancer cell lines, they showed that inflammation ... […]
- Phenols in purple corn fight diabetes, obesity, inflammation in mouse cells on April 16, 2019 at 6:32 am
Scientists at the University of Illinois have developed new hybrids of purple corn containing different combinations of phytochemicals that may fight obesity, inflammation and diabetes, a new study in ... […]
via Bing News